Delhi HC directs DCGI to give licence of cancer drug to Cipla
The Delhi High Court allowed Pharma company Cipla to produce the generic version of the anti-cancer drug Nexavar and directed the drug regulator to grant it licence. Earlier, German drug major Bayer Healthcare had filed a suit against Cipla stating that they do not have the right to manufacture the drug as the sole [...]